Asset Details
Do you wish to reserve the book?
Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives
Do you wish to request the book?
Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives
2024
Overview
Gastrointestinal (GI) sequelae, such as vomiting, hyperacidity, dysphagia, dysmotility, and diarrhea, are nearly universal among patients with nephropathic cystinosis. These complications result from disease processes (e.g., kidney disease, cystine crystal accumulation in the GI tract) and side effects of treatments (e.g., cysteamine, immunosuppressive therapy). GI involvement can negatively impact patient well-being and jeopardize disease outcomes by compromising drug absorption and patient adherence to the strict treatment regimen required to manage cystinosis. Given improved life expectancy due to advances in kidney transplantation and the transformative impact of cystine-depleting therapy, nephrologists are increasingly focused on addressing extra-renal complications and quality of life in patients with cystinosis. However, there is a lack of clinical data and guidance to inform GI-related monitoring, interventions, and referrals by nephrologists. Various publications have examined the prevalence and pathophysiology of selected GI complications in cystinosis, but none have summarized the full picture or provided guidance based on the literature and expert experience. We aim to comprehensively review GI sequelae associated with cystinosis and its treatments and to discuss approaches for monitoring and managing these complications, including the involvement of gastroenterology and other disciplines.
Publisher
Springer Berlin Heidelberg,Springer,Springer Nature B.V
Subject
/ Cysteamine - administration & dosage
/ Cysteamine - therapeutic use
/ Cystine Depleting Agents - administration & dosage
/ Cystine Depleting Agents - therapeutic use
/ Diarrhea
/ Gastrointestinal Diseases - diagnosis
/ Gastrointestinal Diseases - etiology
/ Gastrointestinal Diseases - therapy
/ Humans
/ Medicine
/ Patients
/ Review
/ Urology
